RICHARD ERIC DAVIS to I-kappa B Kinase
This is a "connection" page, showing publications RICHARD ERIC DAVIS has written about I-kappa B Kinase.
Connection Strength
0.238
-
Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa. J Nat Prod. 2009 Mar 27; 72(3):336-9.
Score: 0.078
-
Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen. Proc Natl Acad Sci U S A. 2008 Dec 30; 105(52):20798-803.
Score: 0.076
-
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 2009 Mar 05; 458(7234):92-6.
Score: 0.019
-
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar 21; 319(5870):1676-9.
Score: 0.018
-
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007 Aug; 12(2):115-30.
Score: 0.017
-
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res. 2005 Jan 01; 11(1):28-40.
Score: 0.015
-
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood. 2005 Apr 01; 105(7):2891-9.
Score: 0.014